Eagle Pharmaceuticals, Inc. Reports First Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Eagle Pharmaceuticals (EGRX) Misses Q1 EPS by 9c
May 12, 2015 6:55 AM EDTEagle Pharmaceuticals (NASDAQ: EGRX) reported Q1 EPS of $1.38, $0.09 worse than the analyst estimate of $1.47. Revenue for the quarter came in at $36.3 million versus the consensus estimate of $3.41 million.
For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.
... More


